May 01, 2008
BD Announces CE Marking of the BD GeneOhm™ VanR Molecular Test for the Rapid Detection of Vancomycin Resistance
|
May 01, 2008
BD Biosciences Announces Agreement with 3-D Matrix to Market BD™ PuraMatrix™ Peptide Hydrogel Products to the Research Community
|
April 23, 2008
BD Announces Results for Second Fiscal Quarter
|
April 23, 2008
CEO Ed Ludwig Discusses Second Quarter Fiscal 2008 Results on CNBC (Video)
|
April 08, 2008
BD Opens New Manufacturing Facility in Suzhou, China to Produce Rapid Diagnostic Products
|
April 04, 2008
BD Biosciences Announces Winners of 2007 Research Grant Program
|
April 03, 2008
BD Biosciences Launches New BD™ High-Performance Calcium Dye Assay Kit
|
March 27, 2008
BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana
|
March 26, 2008
BD Venflon™ Pro Safety Catheter Wins Award in Prestigious International Design Competition
|
March 26, 2008
BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference
|
March 26, 2008
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
March 18, 2008
BD Board of Directors Elects John R. Considine as Vice Chairman and Member of the Board of Directors
|
March 17, 2008
BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates
|
February 13, 2008
First European Application Filed for Product Using Innovative Intradermal Microinjection System BD Soluvia™
|
January 29, 2008
BD Board Declares Dividend
|
January 29, 2008
BD Announces Results of Shareholder Votes at Annual Meeting
|
January 28, 2008
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
|
January 25, 2008
CEO Ed Ludwig Discusses First Quarter Fiscal 2008 Results on CNBC (Video)
|
January 24, 2008
BD Announces Results for First Fiscal Quarter
|
January 18, 2008
BD Biosciences Launches New BD FACSAria™ II Cell Sorting System
|
January 16, 2008
BD Announces Webcast of Annual Meeting of Shareholders
|
January 04, 2008
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
|
January 02, 2008
BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
|
December 27, 2007
BD to Present at the 26th Annual JPMorgan Healthcare Conference
|
December 20, 2007
BD Announces CE Marking of Rapid Molecular Test to Identify Superbug from Nasal and Wound Specimens
|
December 18, 2007
UCLH Study Demonstrates Rapid Patient Screening Could Cut MRSA Rates By Almost 40 Per Cent
|
November 21, 2007
Next Generation of BD Visitec™ Disposable Instruments Designed to Meet the Needs of Ophthalmic Surgery
|
November 20, 2007
BD Board Declares Dividend
|
November 07, 2007
BD to Present at Investor Healthcare Conferences
|
November 05, 2007
BD and FIND Help Address Emergence of XDR-TB With New Pricing Agreement for Liquid Culture System
|
November 02, 2007
BD Board of Directors Elects Cathy E. Minehan
|
November 01, 2007
BD Announces Results For Fourth Fiscal Quarter and Full Year
|
October 31, 2007
BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
|
October 22, 2007
CEO Ed Ludwig Discusses Healthcare-associated Infections on CNBC (Video)
|
October 09, 2007
BD Biosciences Opens Education Center in Rockville, Maryland for High-Content Bioimaging Customers
|
October 01, 2007
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
September 11, 2007
BD Announces FDA 510(k) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
|
September 08, 2007
New Ophthalmic Safety Knives with BD Atomic Edge™ Technology Approach Diamond-Like Sharpness and Single-Use Convenience
|
August 30, 2007
BD to Present at the Bear Stearns 20th Annual Healthcare Conference
|
August 06, 2007
BD Taps Seasoned Executive and Researcher to Serve as Company's Chief Technology Officer
|
July 26, 2007
BD to Expand European Distribution Center in Temse, Belgium
|
July 26, 2007
BD Announces Results for Third Fiscal Quarter
|
July 24, 2007
BD Board of Directors Elects Marshall O. Larsen
|
July 24, 2007
BD Board Declares Dividend and Authorizes Additional Share Repurchases
|
June 29, 2007
BD Biosciences Releases BD FACSDiva™ 6.0 Software
|
June 29, 2007
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
June 28, 2007
BD Biosciences Announces 2007 Research Grant Program
|
June 15, 2007
BD Biosciences and StemCell Technologies Launch Advanced Culture Environment for Human Embryonic Stem Cell (hESC) Research
|
June 14, 2007
BD Medical - Ophthalmic Systems Celebrates 75 Years of Beaver Surgical Products
|
June 14, 2007
BD Biosciences and StemCell Technologies Sign License Agreements with WARF to Commercialize Novel Culture Media and Surfaces for Human Embryonic Stem Cell Research
|
June 04, 2007
BD and EPSC Announce Launch of specimencare.com
|
June 04, 2007
BD to Present at the Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference
|
May 22, 2007
BD Board Declares Dividend
|
May 22, 2007
BD Demonstrates Microbiology Automation Designed to Improve Laboratory Efficiency of Microbial Identification and Susceptibility Testing
|
May 21, 2007
BD Receives CE Mark Approval for Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
|
May 18, 2007
BD to Present at the Bank of America 2007 Healthcare Conference
|
May 17, 2007
BD to Present at the Sanford C. Bernstein & Co., LLC Twenty-Third Annual Strategic Decisions Conference
|
May 10, 2007
BD Biosciences to Expand Manufacturing in Durham, North Carolina
|
April 27, 2007
BD Biosciences Earns Top Honors for Flow Cytometry-based Cell Biology Instruments at Prestigious Life Science Industry Awards
|
April 26, 2007
Variant Strain of Chlamydia May Go Undetected
|
April 25, 2007
BD Discloses Notice of Arbitration and Dispute Resolution Proceedings
|
April 25, 2007
BD Announces FDA 510(k) Submission of Two Hour Test to Identify Superbug in Patients with Positive Blood Cultures
|
April 25, 2007
BD Announces Results for Second Fiscal Quarter
|
April 18, 2007
BD to Present at the 2007 Morgan Stanley Global Healthcare Unplugged Conference
|
March 28, 2007
BD Medical Launches the BD AutoShield™ Pen Needle
|
March 26, 2007
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
March 26, 2007
BD and Direct Relief International Launch Volunteer Service Program to Improve Healthcare in Ghana
|
March 22, 2007
BD and FIND Announce Expanded Collaboration to Improve Tuberculosis Diagnostics Worldwide
|
March 13, 2007
BD Move Signals Commitment to Oxford
|
March 09, 2007
BD Honored as One of "America's Most Admired Companies" in FORTUNE Magazine's Annual Rankings
|
March 01, 2007
BD to Present at the Cowen and Company 27th Annual Healthcare Conference
|
February 26, 2007
BD Biosciences and Roche Collaborate to Advance the Study of Cell Signal Transduction through New Phosphorylation Site Antibody Targets and Applications
|
February 14, 2007
BD Announces 2007 BD Biosciences Technology Days
|
February 08, 2007
BD Commits $34 Million for Major Expansion in Québec
|
February 07, 2007
BD Medical Creates BD FluStock(SM) Planning Service to Aid Pandemic Influenza Preparedness Efforts in Hospitals
|
January 30, 2007
BD Board Declares Dividend
|
January 30, 2007
BD Announces Results of Shareholder Votes at Annual Meeting
|
January 30, 2007
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
|
January 25, 2007
BD Announces Results for First Fiscal Quarter
|
January 11, 2007
BD Announces Webcast of Annual Meeting of Shareholders
|
December 28, 2006
BD to Present at the 25th Annual JPMorgan Healthcare Conference
|
December 21, 2006
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
|
December 20, 2006
BD Completes Acquisition of TriPath Imaging
|
November 30, 2006
BD and International Council of Nurses Collaborate to Address the Health Human Resource Crisis in Africa
|
November 21, 2006
BD Board Declares Dividend
|
November 20, 2006
BD to Present at the Lazard Capital Markets Third Annual Life Sciences Conference
|
November 11, 2006
Responding to the Needs of the Ophthalmic Surgical Team: BD Provides Enhanced Safety Solutions
|
November 06, 2006
BD to Present at the ArgusVision 2007: Eyes on the Future Conference
|
November 02, 2006
BD Announces Results for Fourth Fiscal Quarter and Full Year
|
November 01, 2006
BD to Present at the CIBC World Markets Seventeenth Annual Healthcare Conference
|
October 30, 2006
BD Biosciences Announces Immunology Grant Program Winners
|
October 19, 2006
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
October 17, 2006
BD Medical Worksite Diabetes Prevention Program Yields Successful Results
|
September 28, 2006
BD Announces Plan to Exit Blood Glucose Monitoring Market
|
September 26, 2006
BD Board of Directors Elects Dr. Claire M. Fraser-Liggett
|
September 18, 2006
BD Biosciences Releases BD FACSCanto™ II Flow Cytometry System for In Vitro Diagnostics Use
|
September 14, 2006
BD Medical Extends Broader Offering of Needle Technology Designed to Improve Patient Comfort and Healthcare Worker Safety
|
September 08, 2006
BD to Acquire TriPath Imaging, Inc.
|
September 05, 2006
BD to Present at the Bear Stearns 19th Annual Healthcare Conference
|
August 31, 2006
BD to Present at the Thomas Weisel Partners Healthcare Conference 2006
|
August 14, 2006
BD Makes Filing to Report Bid to Acquire TriPath Imaging, Inc.
|
August 12, 2006
Research Shows CD4 Testing Cost-Effective for HIV Patients in Areas Lacking Access to Second-Line ARV Treatments
|
August 12, 2006
BD Diagnostics Announces Availability in Africa of New CD4 Stabilization Blood Collection Technology
|
August 09, 2006
BD Biosciences Empowers Advances in Immune System Disease Research
|
August 08, 2006
MedCentral Health System Implements BD.id™ Patient Identification System for Specimen Management
|
August 07, 2006
BD Biosciences Announces Extension of Grant Program for Immunology Researchers
|
July 28, 2006
CEO Ed Ludwig Discusses Third Fiscal Quarter Results on CNBC (Video)
|
July 28, 2006
BD Announces Results for Third Fiscal Quarter
|
July 25, 2006
BD Board of Directors Elects Dr. Adel A.F. Mahmoud
|
July 25, 2006
BD Board Declares Dividend
|
July 21, 2006
Wyeth Infant Meningitis Vaccine Available for Delivery with BD Hypak SCF™ Prefill System
|
July 18, 2006
BD Invests US$16 Million to Establish a Plant in China To Produce Rapid Diagnostic Products for Flu and Virus Infection
|
July 17, 2006
25 Years of Manufacturing Excellence in Plymouth
|
July 17, 2006
BD Medical Announces Positive Results for New York City BD Diabetes Makeover(SM) Program
|
June 15, 2006
BD Diagnostics Announces Agreement with BioReference Laboratories for BD Viper™ Robotic Instrumentation and Molecular Testing of Sexually Transmitted Infections
|
June 15, 2006
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
June 12, 2006
BD and Catholic Medical Mission Board Partner to Bolster Zambian Healthcare Clinics' HIV/AIDS Efforts
|
June 06, 2006
BD to Present at the Goldman Sachs 27th Annual Global Healthcare Conference
|
May 23, 2006
BD Board Declares Dividend
|
May 10, 2006
BD to Present at the Bank of America Healthcare Conference 2006
|
April 26, 2006
BD Announces Results for Second Fiscal Quarter
|
April 24, 2006
BD to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2006
|
April 12, 2006
BD Develops Its Global Manufacturing Centre in Drogheda
|
April 06, 2006
NYC's North General Hospital to Host BD Diabetes Makeover Program
|
March 28, 2006
BD Biosciences Announces Agreement with Dynomics to Collaborate on Novel Cancer Diagnostic Technology
|
March 27, 2006
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
March 20, 2006
BD Medical to Support Gary Hall, Jr. Through 2008 Olympic Games
|
March 06, 2006
BD to Present at the SG Cowen & Co. 26th Annual Health Care Conference
|
February 23, 2006
BD Diagnostics Announces Multi-year Agreement with Quest Diagnostics
for BD Viper™ System
|
February 21, 2006
VaxGen and BD to Jointly Evaluate Novel Dermal Injection Technology for Delivery of VaxGen's Anthrax Vaccine
|
February 17, 2006
BD Medical Notifies Blood Glucose Monitor Users in the US and Canada About a Potential Malfunction with its Meters
|
February 14, 2006
BD Completes Acquisition of GeneOhm Sciences, Inc.
|
January 31, 2006
BD Medical Continues Advancement of Flu Vaccine Delivery Technologies
|
January 31, 2006
BD Board Declares Dividend
|
January 30, 2006
BD Medical Announces New Regional Anesthesia Tray Business
|
January 26, 2006
BD Announces Results for First Fiscal Quarter
|
January 24, 2006
BD Announces Webcast of Annual Meeting of Shareholders
|
January 10, 2006
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
|
January 10, 2006
BD Announces Agreement to Acquire GeneOhm Sciences, Inc.
|
January 09, 2006
BD Diagnostics Announces FDA 510(k) clearance of the BD Viper™ System
|
January 04, 2006
BD Blood Glucose Monitors - Product Notification
|
December 28, 2005
BD to Present at the 24th Annual JPMorgan Healthcare Conference
|
December 21, 2005
BD Micro-Delivery System Licensed by Sanofi Pasteur
|
December 20, 2005
BD to Allow Poison Pill to Expire; also Adopts New Policy Regarding Election of Directors
|
December 13, 2005
BD Diabetes Makeover Program Continues to Yield Positive Results
|
November 22, 2005
BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases
|
November 10, 2005
BD Diagnostics and TimeMed Collaborate on First Notched Overlabel for Blood Collection Tubes
|
November 07, 2005
BD Biosciences to Establish Manufacturing in Puerto Rico
|
November 07, 2005
BD to Present at the 2005 Credit Suisse First Boston Health Care Conference
|
November 03, 2005
CEO Ed Ludwig Discusses Fourth Fiscal Quarter and Full Year Results on CNBC
|
November 03, 2005
BD Announces Results for Fourth Fiscal Quarter and Full Year
|
November 02, 2005
American Red Cross and BD Announce Expanded Collaboration to Support Measles Initiative
|
November 02, 2005
BD to Present at CIBC World Markets Healthcare Conference
|
October 28, 2005
BD Diabetes Makeover Teams with dLife Television
|
October 25, 2005
BD Expands Research and Data Hub in Research Triangle Park
|
October 19, 2005
BD Diagnostics Announces FDA 501(k) Clearance for BD ProbeTec™ Urine Preservative Transport
|
October 18, 2005
BD to Support TIME Global Health Summit, Nov. 1-3, 2005
|
October 05, 2005
Jackson-Madison County General Hospital to Implement BD.id™ Patient Identification System for Specimen Management
|
September 27, 2005
BD Diagnostics Announces FDA 510(k) Clearance of BD Directigen™ EZ Flu A+B Test
|
September 22, 2005
BD Announces Preparation Efforts Ahead of Hurricane Rita
|
September 20, 2005
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
September 14, 2005
BD Supplements Hurricane Katrina Relief Contribution with Medical Product Donations
|
September 01, 2005
BD Donates $500,000 to Hurricane Katrina Disaster Relief Efforts
|
September 01, 2005
BD to Present at Bear Stearns 18th Annual Healthcare Conference
|
August 30, 2005
BD to Present at Thomas Weisel Partners Healthcare Tailwinds Conference
|
August 22, 2005
BD Medical Continues Efforts to Advance Operating Room Safety
|
August 12, 2005
BD Diabetes Care Announces Successful Results of DC Diabetes Makeover Initiative
|
August 02, 2005
BD Launches New Web Resource Emphasizing Importance/Value of Dose-Sparing Injection Devices (PDF)
|
July 29, 2005
BD Announces Launch of Online Store
|
July 27, 2005
Single-Use Blood Collection Devices Help Ensure Safety of Patients and Healthcare Workers (PDF)
|
July 26, 2005
BD Board Declares Dividend
|
July 22, 2005
BD Announces Results for Third Fiscal Quarter
|
July 22, 2005
CEO Ed Ludwig Discusses Results on CNBC
|
July 13, 2005
BD Diabetes Makeover Program Comes to Nation's Capital
|
July 01, 2005
BD Announces Agreement to Sell Clontech
|
June 09, 2005
BD to Present at Goldman Sachs Twenty-Sixth Annual Global Healthcare Conference
|
May 25, 2005
BD to Establish Major Distribution Center in Plainfield, Indiana
|
May 24, 2005
BD Board Declares Dividend
|
May 18, 2005
PreAnalytiX PAXgene™ Blood RNA System is Industry's First to Receive 510(K) Clearance From FDA and to Attain CE Mark
|
May 18, 2005
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
May 09, 2005
BD to Present at Banc of America Securities Health Care Conference 2005
|
May 04, 2005
BD and CMMB Join Forces to Address the Challenge of HIV/AIDS Pandemic in Zambia
|
May 04, 2005
BD to Present at R. W. Baird 2005 Growth Stock Conference
|
May 03, 2005
BD Announces Acquisition of Protein Separation Technology from FFE Weber GmbH
|
April 28, 2005
BD to Present at Morgan Stanley Third Annual Global Healthcare Conference
|
April 27, 2005
BD Announces Results for Second Fiscal Quarter
|
April 15, 2005
Pioneer in Blade Technology Introduces First Single-Use Cataract Safety Knife System
|
March 24, 2005
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
March 10, 2005
BD to Present at SG Cowen 25th Annual Health Care Conference
|
March 09, 2005
BD Announces Launch of Two New Monomeric Fluorescent Proteins for Life Science Researchers
|
February 23, 2005
BD Named One of America's Most Admired Companies in FORTUNE Magazine's Annual Survey
|
February 17, 2005
BD Commits $31 Million for Major Expansion in Sandy, Utah
|
February 02, 2005
BD to Present at Merrill Lynch 2005 Global Pharmaceutical, Biotechnology and Medical Device Conference
|
February 01, 2005
BD Announces Results of Shareholder Votes at Annual Meeting
|
February 01, 2005
BD Board Declares Dividend
|
January 28, 2005
BD Statement Regarding Worldwide Voluntary Recall of BD ProbeTec™ ET Urine Processing Kits
|
January 26, 2005
BD Announces Webcast of Annual Meeting of Shareholders
|
January 26, 2005
BD Announces Results for Fiscal First Quarter
|
January 20, 2005
BD to Present at 17th Annual Piper Jaffray Health Care Conference
|
January 14, 2005
BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call
|
January 10, 2005
BD Announces FDA 510(k) clearance of simplified test for detection of methicillin-resistant Staphylococcus aureus (MRSA)
|
January 05, 2005
BD to Present at 23rd Annual JPMorgan Healthcare Conference
|
January 04, 2005
BD Announces Full Release of Medication Maximizing Syringe
|
January 04, 2005
BD Announces Tsunami Relief Efforts
|
December 20, 2004
BD Biosciences Supports World AIDS Day
|
December 16, 2004
Hindustan Latex and BD Launch Auto-Disable Syringes in India
|
December 15, 2004
FIND and BD Combine International Efforts to Improve Rapid Tuberculosis Diagnosis for HIV-positive Patients in Developing Countries
|
November 23, 2004
BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases
|
November 23, 2004
BD Board of Directors Elects Gary A. Mecklenburg
|
November 22, 2004
BD Releases New Version of BD.id™ Patient Identification System for Specimen Management
|
November 12, 2004
BD Commits to Major Expansion in Columbus, Nebraska
|
November 11, 2004
Meeting the Challenge of Influenza
|
November 09, 2004
Cellomics and BD Sign License Agreement to Further Expand Availability of High Content Screening
|
November 05, 2004
BD Presents Diabetes Makeover to Inspire Better Diabetes Care
|
November 04, 2004
BD Announces Fiscal Fourth Quarter and Full Year Results
|
November 04, 2004
FDA Alternate Site Clearance Offers BD Blood Glucose Meter Users More Convenience
|
October 26, 2004
BD to Present at CIBC World Markets Healthcare Conference
|
October 14, 2004
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
October 06, 2004
BD Launches Dora the Explorer™ Digital Thermometer
|
October 04, 2004
BD Announces Plan to Sell Clontech
|
September 21, 2004
BD Biosciences Releases BD FACSCanto™ Flow Cytometry System for Clinical Diagnostics
|
September 16, 2004
BD to Present at UBS Global Life Sciences Conference
|
September 14, 2004
BD Can Help Healthcare Providers Maximize Positive Outcomes During Flu Season
|
September 07, 2004
BD to Present at Bear Stearns 17th Annual Healthcare Conference
|
September 02, 2004
BD to Present at Thomas Weisel Partners Healthcare Tailwinds 2004 Conference
|
September 01, 2004
2004 Olympic Gold-Medalist Swimmer Gary Hall Jr. Joins Forces with BD to Inspire Americans to Improve Their Diabetes Care
|
July 27, 2004
BD, Sumter County Announce Major Facility Expansion
|
July 27, 2004
BD Biosciences Pharmingen Designated One of the Best Workplaces for Commuterssm by U.S. EPA and DOT
|
July 27, 2004
BD Board Declares Dividend
|
July 22, 2004
BD Announces Results for Fiscal Third Quarter
|
July 12, 2004
BD Highlights Social Responsibility in First Global Corporate Citizenship Report
|
July 08, 2004
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
July 02, 2004
BD Announces Settlement of Pending Lawsuit
|
July 01, 2004
BD Announces Acquisition of Atto Bioscience, Inc.
|
June 29, 2004
BD Applauds President's Inclusion Of Vietnam In Global Strategy To Combat HIV/AIDS
|
June 28, 2004
BD FACSArray™ Bioanalyzer is Honored with a 2004 Silver Industrial Design Excellence Award
|
June 16, 2004
Norwalk Hospital to Implement BD.id™ Patient Identification System for Specimen Management
|
June 16, 2004
BD Receives Medical Design Excellence Award - Wireless Blood Glucose Monitor Recognized for Innovation, Design Excellence
|
June 14, 2004
BD Continues to Lead the Way in Drug Delivery Technologies: Launches New Generation of Plastic Prefillable Syringes
|
June 14, 2004
BD Names J. Peter Natale as Chief Information Officer
|
June 10, 2004
BD Submits 510(k) Application to FDA for Alternate Site Testing
|
June 02, 2004
BD to Present at Goldman Sachs Twenty Fifth Annual Global Healthcare Conference
|
May 25, 2004
BD Board Declares Dividend
|
May 24, 2004
BD Announces FDA 510(k) Clearance of Molecular Test for Legionella pneumophila
|
May 12, 2004
BD to Present at Banc of America Securities 2004 Health Care Conference
|
May 11, 2004
BD Biosciences Releases the BD FACSCanto™ Flow Cytometry System
|
May 04, 2004
BD™ Sharps Disposal By Mail System Meets EPA Guidelines, Helps Protect Public Against Injury, Infection
|
April 30, 2004
BD to Present at Morgan Stanley Second Annual Global Healthcare Unplugged Conference
|
April 22, 2004
BD Announces Fiscal Second Quarter Results
|
April 08, 2004
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
March 29, 2004
Basil L. Anderson Elected to BD Board of Directors
|
March 04, 2004
Hepatitis C Treatment Available in Self-Dosing Pen Format
|
February 26, 2004
BD to Present at the SG Cowen 24th Annual Health Care Conference
|
February 23, 2004
BD.id™ Patient Identification System Reduces Specimen Collection Errors by 99.95% at The Valley Hospital
|
February 04, 2004
BD Announces Launch of 1ml Retracting Syringe
|
January 29, 2004
BD Announces Fiscal First Quarter Revenue and Earnings Growth
|
January 29, 2004
BD Initiates Voluntary Recall of Certain BD™ Test Strips
|
January 28, 2004
BD to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
|
January 27, 2004
BD Board Declares Dividend
|
January 27, 2004
BD Board Authorizes Additional Share Repurchases
|
January 13, 2004
BD to Announce First Fiscal Quarter Results
|
December 29, 2003
BD Names Jeffrey S. Sherman Vice President and General Counsel
|
December 02, 2003
BD to Present at Merrill Lynch Medical Technology University Conference
|
November 24, 2003
BD Board Declares Dividend Increase of 50%
|
November 06, 2003
BD Announces Record Fiscal Fourth Quarter and Full Year Revenues
|
November 06, 2003
BD Applauds Senate Action To Prevent Unsafe Medical Practices That Can Cause HIV/AIDS Spread In Africa
|
November 05, 2003
BD to Present at Credit Suisse First Boston's Health Care Conference
|
November 05, 2003
BD to Announce Fourth Fiscal Quarter and Year-End Results
|
November 04, 2003
BD to Present at the CIBC World Markets Fourteenth Annual Healthcare Conference
|
October 30, 2003
BD Supplemental Statement Regarding Voluntary Recall of BD ProbeTec™ ET Instrument
|
October 29, 2003
BD Introduces New BD Ultra-Fine™ II, Thinnest Insulin Syringe Needle Available In US
|
October 07, 2003
Park City Solutions Joins BD to Co-Market BD.id™ Patient Identification System
|
September 04, 2003
BD to Present at the Bear Stearns 16th Annual Healthcare Conference
|
August 29, 2003
BD to Present at Thomas Weisel Partners Healthcare Tailwinds 2003 Conference
|
August 22, 2003
BD Statement Regarding Voluntary National Recall of BD ProbeTec™ ET Instrument
|
July 31, 2003
BD to Present at Adams, Harkness & Hill 23rd Annual Summer Seminar
|
July 24, 2003
BD Announces Results for Fiscal Third Quarter
|
July 22, 2003
BD Board Declares Dividend
|
June 30, 2003
BD to Announce Third Fiscal Quarter Results
|
June 05, 2003
BD to Present at Goldman Sachs Twenty Fourth Annual Global Healthcare Conference
|
May 20, 2003
BD Board Declares Dividend
|
May 01, 2003
BD to Present at the 2003 Deutsche Bank Securities Health Care Conference
|
April 25, 2003
BD Announces Fiscal Second Quarter Results
|
April 25, 2003
Webcast Replay - BD 2Q Earnings Conference Call, April 25, 2003, 8:30 AM ET
|
April 24, 2003
BD to Present at Morgan Stanley 1st Annual Healthcare Unplugged Conference
|
April 22, 2003
Edward F. DeGraan Elected to BD Board of Directors
|
April 16, 2003
BD Announces Plans for Discontinuation of Conventional Needle Sales in US Across Many Product Categories
|
April 15, 2003
BD CEO Edward J. Ludwig Selected to Serve on US-Japan Private Sector / Government Commission
|
April 02, 2003
BD to Announce Second Fiscal Quarter Results
|
March 18, 2003
BD to Present at the SG Cowen 23rd Annual Health Care Conference
|
March 14, 2003
BD Names Vincent A. Forlenza President of BD Biosciences
|
February 05, 2003
BD Comments Further on West Pharmaceutical Services Plant Incident
|
February 03, 2003
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
|
January 29, 2003
BD Statement in Response to West Pharmaceutical Services Plant Incident
|
January 28, 2003
BD Board Authorizes Additional Share Repurchases
|
January 28, 2003
BD Board Declares Dividend
|
January 23, 2003
BD Announces Results for Fiscal First Quarter
|
January 16, 2003
BD to Announce First Fiscal Quarter Results
|
January 08, 2003
BD Presents New Blood Glucose Monitoring Products and Announces Strategic Relationships with Medtronic MiniMed and Eli Lilly and Company
|
January 08, 2003
BD Introduces New Systems to Make Diabetes Monitoring and Management Easier, Faster, and Less Painful
|
December 10, 2002
BD to Present New Blood Glucose Monitoring Products
|
November 26, 2002
BD Board Declares Increased Dividend
|
November 06, 2002
BD Announces Record Fiscal Fourth Quarter and Full Year Revenues
|
November 05, 2002
BD to Present at Credit Suisse First Boston Healthcare Conference
|
October 21, 2002
BD to Announce Fourth Fiscal Quarter and Year-End Results
|
October 16, 2002
NJ Governor announces agreement to pilot-test BD Bio-Terror Preparedness Network
|
September 24, 2002
Bertram L. Scott Elected to BD Board of Directors
|
September 23, 2002
BD™ Bifurcated Needle Launched for Smallpox Vaccination Efforts
|
September 04, 2002
BD Director Albert J. Costello Dies at 66
|
August 13, 2002
CEO and CFO submit certifications pursuant to SEC Order and Sarbanes-Oxley Act of 2002
|
August 12, 2002
CEO and CFO submit sworn statements pursuant to SEC Order regarding SEC filings
|
July 26, 2002
U.S. Fund for UNICEF and BD Partner to Accelerate Elimination of Maternal and Neonatal Tetanus
|
July 24, 2002
Letter to the Editor from Chairman, President and CEO Edward J. Ludwig in response to The New York Times article of July 19
|
July 24, 2002
BD Announces Results for Fiscal Third Quarter
|
July 23, 2002
BD Declares Dividend
|
July 19, 2002
Statement from BD in response to The New York Times article
|
May 30, 2002
BD Launches New Retracting Needle Syringe
|
May 21, 2002
BD Declares Dividend
|
April 24, 2002
BD Announces Record $1 Billion Second Quarter Revenues
|
April 16, 2002
BD Biosciences and NuGenesis Technologies Announce Strategic Alliance...
|
April 09, 2002
BD Announces New Safety-Engineered Product Technology
|
April 01, 2002
Wesley J. Howe, Former BD CEO, Dies at 80
|
March 26, 2002
BD to Present at Banc of America Securities Healthcare Conference
|
January 29, 2002
BD Biosciences Enters Into Collaboration With the Harvard Institute of Proteomics to Determine Human Gene Function
|
January 29, 2002
BD to Present at Merrill Lynch Healthcare Conference
|
January 23, 2002
BD Announces Results for Fiscal First Quarter
|
January 22, 2002
BD Declares Dividend
|
January 04, 2002
BD to Present at JP Morgan H&Q Healthcare Conference
|
January 03, 2002
BD to Announce First Fiscal Quarter Results
|
November 27, 2001
Edward J. Ludwig to Become BD Chairman of the Board Effective February 2002
|
November 27, 2001
BD Declares Increased Dividend
|
November 08, 2001
BD to Present at CSFB Health Care Conference
|
November 07, 2001
BD Announces Record Fiscal Fourth Quarter Revenues
|
October 30, 2001
BD to Announce Fourth Fiscal Quarter and Year-End Results
|
September 26, 2001
BD to Present at Bear Stearns Virtual Healthcare Conference
|
September 24, 2001
BD Pledges $1,000,000 to Help Victims and Families; Launches Worldwide Employee Contributions Campaign
|
September 17, 2001
BD Board Authorizes Additional Share Repurchases
|
September 04, 2001
BD to Present at Banc of America Securities Investment Conference
|
July 30, 2001
BD Biosciences To Collaborate With Zyomyx To Apply Antibody Expertise To High Density Protein Biochips
|
July 25, 2001
BD To Present at Adams, Harkness & Hill Summer Seminar
|
July 24, 2001
BD Declares Dividend
|
July 18, 2001
BD Announces Results For Fiscal Third Quarter
|
June 20, 2001
BD Congratulates GlaxoSmithKline on Receiving FDA Approval To Market Prefilled Vaccine System
|
June 13, 2001
BD Biosciences and Dyax Corp. Announce Research Products and Proteomics Alliance
|
June 07, 2001
BD To Present at Goldman Sachs Healthcare Conference
|
June 04, 2001
Nanogen/BD Joint Venture Awarded Its First U.S. Patent
|
June 01, 2001
BD Technologies Hosts Incubator Program Graduation Ceremonies
|
May 22, 2001
BD Declares Dividend
|
May 05, 2001
New UNICEF Greeting Card Celebrates a Mother's Love
|
April 18, 2001
BD Announces Record Revenues for Fiscal Second Quarter
|
April 04, 2001
BD Announces Plans To Introduce Passive, Shielded I.V. Catheter
|
March 22, 2001
BD To Present at Banc of America Securities Healthcare Conference
|
February 22, 2001
BD To Present at Lehman Brothers Healthcare Conference
|
February 01, 2001
BD To Present At Merrill Lynch Conference
|
January 23, 2001
BD Names Dean Paranicas Vice President, Investor Relations and Public Affairs
|
January 23, 2001
BD Declares Dividend
|
January 22, 2001
BD to Present at U.S. Bancorp Piper Jaffray Health Care Conference
|
January 17, 2001
BD Announces Results for Fiscal First Quarter
|
January 11, 2001
BD Announces Webcast of Q1 Conference Call
|
December 20, 2000
BD Signs Agreement to Acquire Gentest Corporation
|
December 15, 2000
Edward J. Ludwig Appointed to U.S. Fund for UNICEF Board of Directors
|
December 14, 2000
BD Names First Winners of Wesley J. Howe Award for Technological Innovation
|
November 28, 2000
BD Praises Recent California Patient Safety Legislation
|
November 28, 2000
BD Elects James Orr to Board of Directors
|
November 28, 2000
BD Declares Increased Dividend
|
November 13, 2000
BD to Present at CSFB Annual Healthcare Conference
|
November 06, 2000
President Clinton Signs Needlestick Safety and Prevention Act;
BD Celebrates Healthcare Worker Safety Law
|
November 06, 2000
BD Announces Record Revenues For Fiscal Fourth Quarter and Full Year
|
November 02, 2000
Live Web Cast of BD Presentation to Investment Community
|
October 27, 2000
BD Praises Senate Passage of Needlestick Safety and Prevention Act
|
September 26, 2000
BD Names Stephen Mock Vice President, Investor and Public Relations
|
September 26, 2000
BD Announces Program To Reduce Costs, Improve Financial Performance And Support Major Product Initiatives
|
September 20, 2000
BD Commends Introduction of New Needlestick Prevention Bill
|
August 14, 2000
Hepatitis B Immunization Campaign Launched in Indonesia Using BD Uniject™ Injection Device
|
July 25, 2000
BD Declares Dividend
|
July 20, 2000
BD Announces Results For Third Fiscal Quarter -- Safety and Biosciences Sales Add To Top Line Growth
|
July 19, 2000
BD Launches Safety Compliance Initiative for Needlestick Prevention
|
June 29, 2000
BD Applauds Consensus on Needlestick Prevention Legislation and Health Care Worker Safety at Congressional Hearing
|
June 05, 2000
BD Wins Major Patent Infringement Lawsuit
|
June 05, 2000
BD Names Bridget Healy General Counsel
|
May 30, 2000
BD Names John Considine Executive VP and Chief Financial Officer
|
May 23, 2000
BD Declares Dividend
|
April 25, 2000
Chlamydia and Gonorrhea Now Simple to Diagnose
|
April 24, 2000
BD Named Official Supplier by Major League Soccer (MLS)
|
April 19, 2000
BD Provides Unrestricted Grant to Support Needle Safety Campaign
|
April 18, 2000
BD Announces Strong Results for Second Fiscal Quarter and Confirms Outlook for Year
|
April 17, 2000
BD, Guidant, and Boston Scientific Join Leading Healthcare Companies
New E-Business Venture
|
April 13, 2000
"The Latest Injection and Blood Collection Advancements" featuring BD products on CNBC
|
March 21, 2000
Patient Safety at Your Fingertips; BD Develops Hand-Held Device Solutions to Reduce Medication Errors
|
February 24, 2000
Hospital Risk Managers Find Medication Error a Significant Problem; BD Survey Reveals Reporting Errors Not Rewarded
|
February 23, 2000
BD Expects Rapid Resumption of Product Supply Following Voluntary Recall; Offers Alternate Product at No Charge in Interim and Confirms E.P.S. Expectations
|
January 26, 2000
BD Declares Dividend
|
January 20, 2000
BD Reports Results for Fiscal First Quarter; Revenues Increase 12 Percent
|
January 06, 2000
New Jersey Governor Whitman Signs Needle Safety Bill
|
December 22, 1999
BD Makes Additional Contribution to UNICEF's Partnership to Eliminate Maternal and Neonatal Tetanus Worldwide
|
December 07, 1999
BD Helps Healthcare Organizations Reduce Medical Errors
|
November 23, 1999
BD Declares Increased Dividend
|
November 23, 1999
BD Names Robert M. Hallenbeck VP and General Counsel
|
November 22, 1999
BD Announces Edward J. Ludwig Elected to the Board of Directors and CEO
|
November 21, 1999
Bill and Melinda Gates Foundation Joins Unicef and BD in Effort To Prevent Newborn Deaths in Developing World
|
November 08, 1999
BD Announces FDA Clearance of BDProbeTec™ ET System For the Detection of Chlamydia and Gonorrhea
|
November 04, 1999
BD (Becton, Dickinson and Company) Announces Record Revenues for Fiscal Year
|
October 14, 1999
BD QBC Star™ Centrifugal Hematology System Simplifies In-Office CBC Testing
|
October 13, 1999
BD Announces Chief Financial Officer Is Leaving the Company
|
October 05, 1999
Becton, Dickinson and Company and Haselmeier GmbH Agree to Form Joint Venture
|
September 28, 1999
CIO Magazine Honors BD for Innovative Information Technology Practices
|
September 23, 1999
Two BD Products Win Design Excellence Awards
|
September 14, 1999
First Ever FDA-Cleared Breast Self-Examination Pad to Help Women Now Available in Drug Stores and Major Chains Nationwide
|
September 08, 1999
The International Diabetes Center and BD Fortify Staged Diabetes Management Collaboration
|
August 31, 1999
BD and QIAGEN Agree to form Joint Venture
|
August 31, 1999
BD Acquires SAF-T-MED Advanced Safety Needle Technology
|
August 26, 1999
Becton, Dickinson and Company Completes Acquisition of Clontech Laboratories, Inc.
|
August 18, 1999
Becton Dickinson Introduces a New Global Healthcare Brand
|
July 21, 1999
Becton Dickinson Reports Third Quarter Results
|
July 05, 1999
Gaida Joins BD Healthcare Consulting & Services
|
June 16, 1999
Becton Dickinson Announces National Agreement with Kaiser Permanente
|
June 11, 1999
Join Becton Dickinson at APIC'99
June 21-23, Hyatt Regency, Baltimore, MD
|
May 25, 1999
Becton Dickinson Names Ludwig President
|
May 25, 1999
Becton Dickinson Announces Election of Willard J. Overlock, Jr.
|
May 12, 1999
Becton Dickinson Introduces The MICROTAINER® Brand GENIE™ Lancet
|
May 03, 1999
BD Labware and Kimble/Kontes announce the formation of a collaborative agreement.
|
April 28, 1999
Becton Dickinson and Company Announces Planned Acquisition of Clontech Laboratories, Inc.
|
April 09, 1999
Becton Dickinson Enters Into Collaborative Drug Delivery Agreements with Rhône-Poulenc Rorer
|
March 15, 1999
Becton Dickinson Presents Award at LabAutomation99
|
March 15, 1999
Becton Dickinson Biosciences Leukemia and Lymphoma Product Development Team Volunteers Time at Leukemia Society of America's Cure-a-Thon
|
March 09, 1999
B-D.id and CAP Today Co-Sponsor Survey to Determine Awareness of Medication Administration and Specimen Collection Errors
|
March 01, 1999
Becton Dickinson Expands Growing Anesthesia Business With Acquisition of Kendall Anesthesia Product Line
|
February 25, 1999
BD Enters Molecular Oncology Alliance with Millennium Predictive Medicine
|
February 09, 1999
Becton Dickinson and Company Announces the Acquisition of Biometric Imaging
|
February 04, 1999
Becton Dickinson Supports Operation Smile's "World Journey of Hope '99"
|
February 04, 1999
Becton Dickinson Introduces Plastic-Coated Micro-Hematocrits
|
February 02, 1999
Becton Dickinson Introduces Quikheel™ Lancets for Infants and Preemies
|
February 02, 1999
Becton Dickinson Introduces the VACUTAINER® Brand ECLIPSE™ Blood Collection Needle
|
January 26, 1999
Becton Dickinson Acquires Luther Medical Products
|
January 26, 1999
Becton Dickinson Declares Dividend
|
January 21, 1999
Asia's Largest Hypodermic Manufacturing Facilities Established In Bawal, Haryana
|
January 21, 1999
Becton Dickinson Reports 16 Percent E.P.S. Increase For Fiscal First Quarter; Revenues Increase 10 Percent
|
January 01, 1999
BD to Present at CIBC World Markets Healthcare Conference
|
December 14, 1998
Becton Dickinson Acquires New Advanced Protection Technology
|
November 23, 1998
Becton Dickinson Declares Increased Dividend
|
November 13, 1998
Castellini Receives Award in Singapore
|
November 05, 1998
Becton Dickinson Announces Record Revenues For Fiscal Year
|
October 22, 1998
Becton Dickinson Donation Supports Romanian Measles Elimination Campaign
|
September 03, 1998
|
![[spacer image]](/images/shadow_top_left.gif){kind=small}
![[spacer image]](/images/spacer.gif){kind=small}
![[spacer image]](/images/spacer_white.gif){kind=small}
![[spacer image]](/images/spacer_gray.gif){kind=small}